| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 437 |
| 1 | MACITENTAN | 273 |
| 2 | SILDENAFIL CITRATE | 273 |
| 3 | EPOPROSTENOL | 253 |
| 4 | TADALAFIL | 252 |
| 5 | FUROSEMIDE | 229 |
| 6 | ASPIRIN | 217 |
| 7 | ASPIRIN 325 MG | 214 |
| 8 | ASPIRIN 81 MG | 214 |
| 9 | AMBRISENTAN | 199 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 253 | 0.0193 |
| 1 | FOSCARBIDOPA/FOSLEVODOPA | 117 | 0.0133 |
| 2 | NERATINIB | 16 | 0.0069 |
| 3 | SOTATERCEPT-CSRK | 37 | 0.0060 |
| 4 | TIROFIBAN | 17 | 0.0058 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 35 | 0.0042 |
| 6 | MACITENTAN | 273 | 0.0039 |
| 7 | TREPROSTINIL | 437 | 0.0034 |
| 8 | ERGOCALCIFEROL | 101 | 0.0034 |
| 9 | RIOCIGUAT | 96 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 661 |
| 1 | Endothelin Receptor Antagonist [EPC] | 461 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 341 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 335 |
| 4 | Factor Xa Inhibitor [EPC] | 305 |
| 5 | Loop Diuretic [EPC] | 289 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 225 |
| 7 | Corticosteroid [EPC] | 216 |
| 8 | Osmotic Laxative [EPC] | 192 |
| 9 | Benzodiazepine [EPC] | 128 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-coagulant [EPC] | 20 | 0.0054 |
| 1 | Prostacycline Vasodilator [EPC] | 661 | 0.0048 |
| 2 | Provitamin D2 Compound [EPC] | 101 | 0.0034 |
| 3 | Soluble Guanylate Cyclase Stimulator [EPC] | 96 | 0.0028 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 341 | 0.0025 |
| 5 | Endothelin Receptor Antagonist [EPC] | 461 | 0.0023 |
| 6 | Catechol-O-Methyltransferase Inhibitor [EPC] | 11 | 0.0022 |
| 7 | Humanized Monoclonal Antibody Fragment [EPC] | 3 | 0.0021 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 28 | 0.0021 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 4 | 0.0019 |